NOV 09, 2017 6:00 AM PST

Blood trails: nanotechnology-enabled biomarker quantification for early disease detection

Speaker

Abstract

Dr. Tony Hu’s research focuses on developing and validating integrated nanotechnique-based strategies for marker discovery and molecular diagnostics in peripheral blood samples to provide a translatable solution for personalized medicine. His innovations aim to fill current gaps in early detection, real-time therapy monitoring and effective prognostics. Instead of competing on lowering the detection limit of those known markers with poor specificity on disease diagnosis, Hu’s focus is to utilize nanotech-induced capabilities to discover those unknowns and to address major unsolved problems in oncology and infectious diseases.


You May Also Like
NOV 09, 2017 6:00 AM PST

Blood trails: nanotechnology-enabled biomarker quantification for early disease detection



Loading Comments...